Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan to Reduce Mortality in High Risk Cardiac Surgery Patients. A Multicentre Randomized Controlled Trial

NCT00994825 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT00994825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan to Reduce Mortality in High Risk Cardiac Surgery Patients. A Multicentre Randomized Controlled Trial
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
May 31, 2016
Enrollment
1,000 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

low cardiac output syndrome